IE 11 is not supported. For an optimal experience visit our site on another browser.

Kodak pharma deal with U.S. government now on hold


A deal to have Kodak produce pharmaceuticals is now on hold, but some big investors have already cashed out. Wall Street Journal Investing Editor Geoffrey Rogow joins Stephanie Ruhle to explain.